Plenary Speakers

Plenary 1: THE UNIFYING ROLE OF INNATE IMMUNITY IN THE ETIOLOGY AND PATHOGENESIS OF ALZHEIMER’S DISEASE

Rudolph Tanzi (USA)

Plenary 2: UNDERSTANDING HUMAN BRAIN RESILIENCE TO ALZHEIMER’S PATHOLOGY

Teresa Gomez Isla (USA)

Plenary 3: TBA

Roger Nitsch (Switzerland)

Plenary 4: APOE AND TREM2: ZOOMING IN ON CONVERGING MICROGLIAL RESPONSES IN ALZHEIMER’S DISEASE

Guojun Bu (USA)

Plenary 5: NEW INITIATIVES IN DRUG DEVELOPMENT FOR ALS

Angela Genge (Canada)

Plenary 6: NONINVASIVE SENSORY STIMULATION TO TREAT ALZHEIMER’S DISEASE

Li-Huei Tsai (USA)